The cost effectiveness of BUCCOLAM® (midazolam oromucosal solution) for the treatment of prolonged acute epileptic seizures in the UK; a hybrid model solution
Publication Type:
Poster
Citation:
Lee D, Gladwell D, Batty AJ, Brereton N and Tate E. The cost effectiveness of BUCCOLAM® (midazolam oromucosal solution) for the treatment of prolonged acute epileptic seizures in the UK; a hybrid model solution. 15th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress. Berlin, Germany. 3-7 November 2012. Poster PND37.
